Activation of protease-activated receptor-1 (PAR-1) inhibits neurally evoked chloride secretion in the mouse colon

被引：1
|
作者：
Buresi, MC
Vergnolle, N
Andrade-Gordon, P
Hollenberg, MD
Wallace, JL
Macnaughton, WK
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)80114-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A23 / A23
页数：1
相关论文
共 50 条
  • [41] Biological characterization of ER129614-06, a novel, non-peptide protease-activated receptor-1 (PAR-1) antagonist
    Kogushi, M
    Matsuoka, T
    Kobayashi, H
    Sato, N
    Suzuki, S
    Kawahara, T
    Kajiwara, A
    Hishinuma, I
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 245 - 246
  • [42] Protease-activated receptor 1 (PAR1) inhibits synaptic NMDARs in mouse nigral dopaminergic neurons
    Price, Rachel
    Ferrari, Elena
    Gardoni, Fabrizio
    Mercuri, Nicola Biagio
    Ledonne, Ada
    PHARMACOLOGICAL RESEARCH, 2020, 160
  • [43] Pneumolysin mediates neutrophil: platelet aggregation via a P-selectin- and protease-activated receptor-1 (PAR-1)-dependent mechanism
    Feldman, Charles
    Nel, Jan G.
    Durandt, Chrisna
    Theron, Annette J.
    Tintinger, Gregory R.
    Richards, Guy A.
    Mitchell, Timothy J.
    Anderson, Ronald
    Pool, Roger
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [44] Thrombin-induced Ca2+ mobilization in human gingival fibroblasts is mediated by protease-activated receptor-1 (PAR-1)
    Tanaka, N
    Morita, T
    Nezu, A
    Tanimura, A
    Mizoguchi, I
    Tojyo, Y
    LIFE SCIENCES, 2003, 73 (03) : 301 - 310
  • [45] Role of Matrix Metalloproteinase-1(MMP-1)/Protease-activated Receptor-1(PAR-1) Signaling Pathway in the Cervical Cancer Invasion
    Ning-xia SUN
    Qian ZHAO
    Chen YE
    Yan MA
    Wen LI
    Journal of Reproduction and Contraception, 2014, (01) : 18 - 25
  • [46] Pharmacodynamics and pharmacokinetics of a novel protease-activated receptor (PAR-1) antagonist SCH 530348
    Kosoglou, T
    Reyderman, L
    Fales, RR
    Yang, B
    Keller, R
    Shah, A
    Maxwell, SE
    Veltri, EP
    Cutler, DL
    CIRCULATION, 2005, 112 (17) : U80 - U80
  • [47] In vivo and in vitro effect of a new thrombin protease-activated receptor (PAR-1) antagonist
    Dumas, M.
    Nadal-Wollbold, F.
    Grelac, F.
    Aiach, M.
    Le Grand, B.
    Gaussem, P.
    Bachelot-Loza, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 86 - 86
  • [48] Paradigm of Biased PAR1 (Protease-Activated Receptor-1) Activation and Inhibition in Endothelial Cells Dissected by Phosphoproteomics
    van den Eshof, Bart L.
    Hoogendijk, Arie J.
    Simpson, Pelle J.
    van Alphen, Floris P. J.
    Zanivan, Sara
    Mertens, Koen
    Meijer, Alexander B.
    van den Biggelaar, Maartje
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (10) : 1891 - +
  • [49] Capsazepine partially inhibits neurally mediated gastric mucus secretion following activation of protease-activated receptor 2
    Kawabata, A
    Kinoshita, M
    Kuroda, R
    Kakehi, K
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2002, 29 (04) : 360 - 361
  • [50] Coagulation Factor Xa inhibits cancer cell migration via Protease-activated receptor-1 activation
    Borensztajn, Keren
    Bijlsma, Maarten F.
    Reitsma, Pieter H.
    Peppelenbosch, Maikel R.
    Spek, C. Arnold
    THROMBOSIS RESEARCH, 2009, 124 (02) : 219 - 225
12345